RI-001

· ADMA Biologics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RI-001, covering 2013-04-24 to 2013-04-24. Get the full timeline:

Most recent: Clinical Trial Update: RI-001 in Immunosuppressed Respiratory Syncytial Virus (RSV) Infected Patients at Risk of Lower Tract RSV Illness [Phase 2]

See pricing